Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Saad

Showing results (451-460 of 1,126) with videos related to

Pageof 113
Sort By:
Journal of Surgical Oncology|January 14, 2020
Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical nephroureterectomyGiuseppe Rosiello, Carlotta Palumbo, Marina Deuker, et al.
Asian Journal of Urology|September 30, 2020
Primary lymphomas of the genitourinary tract: A population-based studyCarlotta Palumbo, Elio Mazzone, Francesco A Mistretta, et al.
The Journal of Urology|May 13, 2020
The Impact of Race and Age on Distribution of Metastases in Patients with Prostate CancerLara Franziska Stolzenbach, Giuseppe Rosiello, Marina Deuker, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 15, 2021
Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies - Executive summaryAndrea Kokorovic, Alan I So, Hosam Serag, et al.
Cancer Research|January 19, 2012
p53 inhibits angiogenesis by inducing the production of ArrestenSarah Assadian, Wissal El-Assaad, Xue Q D Wang, et al.
European Urology Focus|July 30, 2017
Survival Outcomes in Octogenarian and Nonagenarian Patients Treated with First-line Androgen Deprivation Therapy for Organ-confined Prostate CancerPaolo Dell'Oglio, Mohamed Bishr, Katharina Boehm, et al.
European Urology|December 19, 2006
Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mLAndrea Gallina, Claudio Jeldres, Felix K-H Chun, et al.
European Journal of Cancer (Oxford, England : 1990)|February 13, 2007
Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screeningGeorg Hutterer, Paul Perrotte, Andrea Gallina, et al.
European Urology Oncology|December 24, 2023
Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO StudyRonald Tutrone, Fred Saad, Daniel J George, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2010
eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progressionLuc Furic, Liwei Rong, Ola Larsson, et al.
Pageof 113

Showing results (451-460 of 1,126) with videos related to

Sort By:
Pageof 113
Journal of Surgical Oncology|January 14, 2020
Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical nephroureterectomyGiuseppe Rosiello, Carlotta Palumbo, Marina Deuker, et al.
Asian Journal of Urology|September 30, 2020
Primary lymphomas of the genitourinary tract: A population-based studyCarlotta Palumbo, Elio Mazzone, Francesco A Mistretta, et al.
The Journal of Urology|May 13, 2020
The Impact of Race and Age on Distribution of Metastases in Patients with Prostate CancerLara Franziska Stolzenbach, Giuseppe Rosiello, Marina Deuker, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 15, 2021
Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies - Executive summaryAndrea Kokorovic, Alan I So, Hosam Serag, et al.
Cancer Research|January 19, 2012
p53 inhibits angiogenesis by inducing the production of ArrestenSarah Assadian, Wissal El-Assaad, Xue Q D Wang, et al.
European Urology Focus|July 30, 2017
Survival Outcomes in Octogenarian and Nonagenarian Patients Treated with First-line Androgen Deprivation Therapy for Organ-confined Prostate CancerPaolo Dell'Oglio, Mohamed Bishr, Katharina Boehm, et al.
European Urology|December 19, 2006
Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mLAndrea Gallina, Claudio Jeldres, Felix K-H Chun, et al.
European Journal of Cancer (Oxford, England : 1990)|February 13, 2007
Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screeningGeorg Hutterer, Paul Perrotte, Andrea Gallina, et al.
European Urology Oncology|December 24, 2023
Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO StudyRonald Tutrone, Fred Saad, Daniel J George, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2010
eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progressionLuc Furic, Liwei Rong, Ola Larsson, et al.
Pageof 113